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Summary 
Recognition of class I MHC antigens involves interac- 
tion between TCRs of cytotoxic T lymphocytes (CTL) 
and the two a helices of MHC molecules. Using a com- 
bined panel of H-2Kb mutants selected by either a CTL 
clone or MAbs, we have shown evidence that the TCRs 
of 59 Kb-specific CTL clones shared a common binding 
pattern on the H-2Kb molecule. Mutationsof amino acid 
residues at the C-terminal regions, but not the Nter- 
minal regions, of the a helices abrogated the recogni- 
tion by the majority of the clones. The data suggests 
that TCRs predominantly recognize the class I MHC 
molecule with an orientation that is parallel to the 
P-pleated strands and diagonal to the a helices. 
Introduction 
The class I major histocompatibility complex (MHC) pro- 
teins play a major role in the immunological process for 
distinguishing self from non-self. They were first discov- 
ered as the target surface antigens by which the immune 
system rejects grafted foreign tissues (Snell et al., 1976; 
Klein, 1966). Their presently known function is as antigen- 
presenting molecules, whereby peptide fragments derived 
from protein components of either infectious agents or 
tumors are translocated to the cell surface (Wabuke- 
Bunoti and Fan, 1963; Townsend et al., 1965; Townsend 
and Bodmer, 1969; van Bleek and Nathenson, 1990; 
Rdtzschke et al., 1990). For both immunological phenom- 
ena, class I MHC molecules induce CD6’ T lymphocyte- 
mediated immune responses that can eliminate the cells 
that express the targeted foreign peptide/MHC antigens 
(Berke, 1995). 
Structurally, the class I MHC molecules are composed 
of an a heavy chain and a noncovalently associated 6 
SThe laboratories of both authors contributed equally to this work. 
BPresent address: Department of Medicine, Richland Memorial Hospi- 
tal, Columbia, South Carolina 29203. 
7Present address: Corixa Corporation, 1124 Columbia Street, Suite 
464, Seattle, Washington 98104. 
chain (j32-microglobulin). The a chain contains a mem- 
brane distal region of two domains (al and a2) that pres- 
ents peptide antigens and a third domain that anchors the 
molecule in the cell membrane. Although highly polymor- 
phic, class I MHC molecules are mostly conserved in their 
three-dimensional structures (Garrett et al., 1989; Young 
et al., 1994; Madden, 1995), and the polymorphism that 
differentiates various MHC alleles and loci is primarily re- 
stricted to the first two domains of the a chain (Nathenson 
et al., 1981; Klein, 1986). Based on functional studies us- 
ing spontaneously occurring H-2bm mutant mice (Geliebter 
et al., 1986, 1987; Nathenson et al., 1986; Hemmi et al., 
1988) and domain shuffling (Allen et al., 1984; Maryanski 
et al., 1987), several groups have previously presented 
evidence that the membrane distal surface of the al and 
a2 domains of murine class I MHC molecules appears 
to be primarily responsible for the interaction with T cell 
receptors (TCRs). The residues inside the cleft between 
the two a helices influence the conformation and composi- 
tion of the bound peptides as shown from the crystal struc- 
tures of the H-2Kb and H-2Db molecules (Fremont et al., 
1992; Zhang et al., 1992; Young et al., 1994), each in 
association with a single peptide, as well as the structures 
of several human HLA molecules (Bjorkman et al., 1987a, 
1987b; Garrett et al., 1989). 
A serological method to select mutagen-induced H-2Kb 
somatic mutants was previously developed by Geier et al. 
(1986) to study the role of individual amino acid residues of 
the Kb molecule in TCR recognition. This powerful method 
enabled us to identify a set of positions scattered on both 
the al and a2 helices that are likely to be involved in direct 
TCR interaction. Mutations at some of these positions ab- 
rogated most of the Kb-specific Tcell recognition, which led 
to our conclusion that TCRs must simultaneously interact 
with both a helices to complete a recognition process (Ajit- 
kumar et al., 1988). Other groups have used different 
means to identify the critical elements in the MHC struc- 
ture that are necessary for properTCR recognition (Koeller 
et al., 1987; Mann et al., 1988; Maryanski et al., 1989; 
Santosdguado et al., 1989; Jaulin et al., 1992) and their 
results were consistent with the notion that the crucial 
structural elements that influence the outcome of antigen 
recognition by cytotoxic T lymphocytes (CTLs) reside in 
the two a helices of MHC molecules. 
The conclusions drawn from the early analysis of the 
antibody-selected H-2Kb mutants are necessarily limited 
due to the small number of antibodies that were available 
for selection. The limited region of antibody binding and 
the way in which antibodies interact with MHC molecules 
posed further restrictions on the scope of the above study. 
Thus, the results from that study represent only a begin- 
ning to provide sufficient information to define the contact 
region between class I MHCs and TCRs. A crucial feature 
of such interaction is that, unlike immunoglobulins, TCRs 
must recognize their antigens in the context of MHC mole- 
cules, a phenomenon known as MHC restriction (Zinker- 
nagel and Doherty, 1979). Such restriction implies that 
productive physical contacts between the TCRs and 
MHCs may be constrained by the structural features of 
both molecules (Cleverie et al., 1989; Davis and Bjorkman, 
1988; Jorgensen et al., 1992). The overall structural varia- 
tion among the class I MHC alleles is small (Young et 
al., 1995; Madden, 1995). The diversity in sequences and 
lengths of the CDR regions of TCRs is also less prominent 
when compared with immunoglobulins (Rock et al., 1994). 
Therefore, it follows that the actual contacts between 
MHCs and TCRs may assume a limited, if not uniform, 
orientation, as opposed to an almost endless possibility 
of antibody-antigen interaction (Amit et al., 1988; Bizeb- 
ard et al., 1995). Jorgensen et al. (1992) recently provided 
strong evidence that there seemed to be a consensus ori- 
entation among the antigen receptors of a group of CD4+ 
T cell hybridomas that interacted with the class II I-Ek mole- 
cule. Hong and coworkers (1992) also demonstrated that 
certain class II MHC regions could be mapped to TCR 
variable domains. These data supported the idea that the 
interaction between TCRs and MHCs may take place in 
a restricted manner. While a number of models have been 
postulated concerning the orientation of TCRs in contact 
with MHC molecules (Novotny et al., 1988; Chothia et al., 
1988; Cleverie et al., 1989; Davis and Bjorkman, 1988; 
Hong et al., 1992; Jorgensen et al., 1992) the fine details 
of such interactions will become more clear only when 
there is a three-dimensional structure of a TCR or of an 
MHC-TCR cocomplex. However, further functional and 
biochemical definition of such interactions in solution is 
necessary not only to guide our understanding of T cell 
biology, but also to verify and amplify the information ob- 
tained from the crystal structure. 
To address the question whether there is a common 
orientation among all the TCRs that specifically recognize 
an MHC molecule, and, if so, what is such an orientation, 
we have tried to map a region on the surface of the Kb 
molecule that reflects the MHC-TCR interface for CTL 
recognition. Our approach has been to expand our previ- 
ous studies on somatic cell mutants by selecting an addi- 
tional set of MHC surface mutants using a CTL clone in- 
stead of monoclonal antibodies (MAbs). Direct Kb mutant 
selection with a BALBlc (H-2d) anti-Kb alloreactive CTL 
clone 110 allowed us to expand our panel of somatic Kb 
structural variants through the isolation of four novel mu- 
tants. Combining these H-2Kb mutants with the previous 
MAb-selected mutants that have single point mutations in 
regions which, owing to structural considerations, could 
involve direct TCR contact, we analyzed the recognition 
patterns of 59 anti-H-2Kb allogeneic and antigen-specific 
CTL clones derived from a variety of origins. This analysis 
revealed that the TCRs appear to interact with a common 
pattern on the H-2Kb molecule. The data suggests that the 
successful recognition of a Kb molecule by a CTL clone 
depends critically on a region that extends from the 
C-terminal region of the al helix to the same region of the 
a2 helix of the Kb protein molecule. A consensus of TCR 
contact area on the H-2Kb is thus proposed, and its implica- 
tions on CTL recognition are discussed. 
Table 1. H-2Kb Somatic Mutants Selected by CTL Clone 110 
Mutants Residue Altered Amino Acid Substitutions 
R8.110.15 24 (al) 
R8.110.43 75 (al) 
R8.110.8 91 (al) 
R8.110.2 158 (a2) 
Gly to Glu (GGG to GAG) 
Arg to Gln (CGA to CAA) 
Gly to Ser (GGC to AGC) 
Ala to Thr (GCC to ACC) 
Results 
Somatic H-2Kb R8 Mutants Selected by CTL Clone 110 
CTL clone 110 was derived from a BALBlc anti-BlO.A@R) 
alloreactive bulk culture and maintained by continuous 
stimulation with irradiated C57BU8 (H-2q spleen cells. It 
was solely specific against the H-2Kb molecule as reported 
(Sheil et al., 1988). The R8 (H-2b x H-2“) cell line was 
subjected to mutagenesis and two weeks of selection by 
clone 110 as described in Experimental Procedures. Of 
the five structural variants selected by clone 110 for their 
resistance to cytolysis, four were found to contain single 
point mutations within the Kb gene that gave rise to single 
amino acid substitutions. The mutations and amino acid 
sequence changes of each of the four mutants are summa- 
rized in Table 1. Not surprisingly, when CTL assays were 
conducted with clone 110, these mutant cell lines were 
resistant to cytolysis even at an effector:target ratio of 
9O:l (Figure l), which demonstrated the drastic negative 
effect of each of these mutations on T cell recognition. 
When tested with other T cell clones and lines, however, 
each of these mutants was resistant to some T cells but still 
susceptible to the cytolysis by others (Sheil et al., 1988). 
Locations of CTL-Selected Kb Mutations 
on the H-2Kb Structure 
To understand the structural basis for the disruptive effect 
of the mutations on T cell recognition, the locations of 
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Figure 1. Recognition of Clone 110 Against the R8 Mutants Selected 
by this Clone 
Both the parental R8 cells and EL4 cells were used as controls. Assays 
were conducted at three different effector:target ratios as indicated, 
and were repeated three times. All four mutants, R8.110.15 (24) 
R8.110.43 (75). R8.110.8 (91) and R8.110.2 (158), were resistant to 
cytolysis by CTL clone 110. 
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likely. Its impact must come through the alteration of the 
set of peptides bound to the H-2Kb molecule. 
Figure 2. Locations of the H-2Kb Mutations Isolated by CTL Clone 110 
and the Recognition Pattern of Clone 110 on the H-2Kb Molecule 
Residue mapping was conducted with graphics program GRASP 
(Nicholls et al., 1991) on the three-dimensional structure of the H-2Kb 
molecule [Zhang et al., 1992). The recognition pattern was compiled 
by testing clone 110 against each of the R8 mutants listed in Table 
2 at two effector:target ratios, 1O:l and 3:l. If cytolysis of a mutant 
by clone 110 was less than 25% of that of the R8 wild-type cells, 
this mutant was considered resistant to the lysis by clone 110, and 
consequently, its mutation was viewed as negatively affecting CTL 
recognition (closed circles). If the cytolysis was between 25% and 
50% of that of R8 wild type, the mutation was considered partially 
affecting 110 recognition (hatched circles). Otherwise, the mutation 
of a mutant cell line was regarded as having no effect on CTL reactivity 
(open circles). But notice that in this particular case, none of 14 muta- 
tions partially affected the recognition of clone 110. Residues 24 and 
91 were represented as closed squares because neither residue met 
our criterion for testing the reactivity pattern of clones 110. The solid 
line outlines the binding area of the TCR of clone 110 on the H-2Kb 
molecule based on the above CTL assay data. 
these mutated residues were mapped on the recently 
solved three-dimensional structure of the Kb molecule 
(Zhang et al., 1992; Fremont et al., 1992). Interestingly, 
we found that the four mutations were each located in a 
different region of the Kb molecule (Figure 2). Arg75 of 
R8.110.43, which has been changed to a Gin, was located 
on the al helix, whereas Ala158 of R8.110.2, which has 
been changed to a Thr, was on the a2 helix. They were 
approximately 28 A from each other across the antigen- 
binding groove. The side chains of both residues were 
found to project into solvent, suggesting that they were 
engaged in direct Kb-TCR interactions. Thus, mutation at 
either of these two positionson the a helical sections could 
impair TCR interactions, presumably without disturbing 
the bound peptides. 
The mutation of mutant R8.110.6 was identified at posi- 
tion 91 on a loop connecting the al helix and the first 6 
strand of the a2 domain. Its side chain pointed towards 
the cell membrane and away from the al/a2 domains, the 
area responsible for TCR interactions. Such a configura- 
tion does not present any apparent structural reason for 
an effect on TCR contacts. The mutation of R8.110.15 
was Gly to a Glu at position 24 located inside the antigen- 
binding groove where direct contact by TCRs is also un- 
Further Refining the Reactivity Pattern 
of the Altoreactive CTL Clone 110 
To refinefurtherour understanding of the reactivity pattern 
of CTL clone 110, a total of 14 R8 mutants (Table 2), includ- 
ing the above two (R8.110.43, Arg75 to Gln and R8.110.2, 
Ala158 to Thr) that were isolated by clone 110, and twelve 
others that were previously selected by MAbs (Geier et 
al., 1986) were combined and tested for recognition. The 
criterion for choosing this panel of mutants was that each 
must have incurred a single point mutation with potential 
TCR contact capacity, i.e., their mutations must be located 
on the surface of either of the two a helices of the Kb 
molecule so that the residues presumably would only inter- 
fere with TCR binding but not the Kb-bound peptides. Thus, 
this panel of Kb structural variants should allow us to ap- 
proach a definition of the interface between the H-2Kb mol- 
ecule and the TCRs recognizing it. By assessing the ability 
of each single point mutation to abrogate the cytotoxicity 
by clone 110, a binding pattern of this TCR was revealed 
and is schematically shown in Figure 2. An interesting 
feature of this contact area on the Kb molecule was that 
it did not cover the entire solvent exposed area of the Kb 
a helices. Based on the CTL assay data, mutations in the 
N-terminal part of the al helix did not impair the recogni- 
tion by clone 110. Gly56 to Glu (R8.8) and Glu58 to Lys 
(R8.9), in spite of both having incurred a drastic amino 
acid residue change at their respective positions, were 
recognized by clone 110 to a similar degree to that of R8 
wild-type cells. In fact, both mutant cell lines were recog- 
nized well by all the CTL clones tested (Figure 3). A similar 
result could be observed for the residues on the N-terminal 
part of the a2 helix. Mutations at positions 138 and 141 
also did not seem to affect the recognition by clone 110. 
Therefore, the contact area between the TCR of clone 110 
and the Kb molecule, when tested with this panel of Kb 
variants, showed a region covering the C-terminal sections 
of both a helices and a large central portion of the antigen- 
binding groove (Figure 2). 
Table 2. H-2Kb Somatic Mutants with Single Point Surface Mutations 
Mutant Residues Altered Amino Acid Substitutions 
R8.8 58 
R9.9 58 
R&110.43 75 
R8.18 79 
R8.24 80 
R8.313 82 
R8.125 90 
R8.127 138 
R8.14 141 
R8.110.2 158 
R8.341 182 
R8.335 188 
R8.10 187 
R8.338 174 
Gly to Glu 
Glu to Lys 
Arg to Gln 
Arg to Lys 
Gly to Glu 
Leu to Phe 
Gly to Asp 
Met to Lys 
Leu to Arg 
Ala to Thr 
Gly to Asp 
Glu to Lys 
Trp to Arg 
Asn to Lys 
Immunity 
576 
Figure3 Recognition of H-2K” Mutants by Allo- 
reactive and Antigen-Specific CTL Clones 
The data shown in this table are derived from 
analysisof 14 H-2Kb mutant and 59CTLclones 
some of which have been previosly reported 
(asterisks: Bluestone et al., 1986; lmarai et al., 
1995). Of the 14 Kb mutants, 75 (R8.110.43) 
and 158(R8.110.2)wereselected by CTLclone 
110 and are reported in this paper. Mutants at 
positions 56 (R8.8) 58 (R&9), and 79 (R8.18) 
were previously selected by MAbs (Geier et al., 
1986). Their mutations were recently deter- 
mined and are also reported here. The muta- 
tions of the rest of the mutants were originally 
published by Ajitkumar et al. (1988) except for 
the mutants at 138 and 174, of which CTL data 
were not reported. 
Quantitation of CTL lysis is described in detail 
in Experimental Procedures. After direct com- 
parison with the cytolysis level of R8 wild-type 
cells, the results are represented as follows: 
closed square, below 25% of lysis of R8; the 
mutation affects the recognition by this clone: 
hatched square, between 250/o-50%; the mu- 
tation partially affects the recognition. Open 
square, above 50%; the mutation has no signif- 
icant impact. 
The Predominant Recognition Pattern on the H-2Kb 
Shared by Kb-Specific TCRs 
We next examined the question of whether the above ob- 
served pattern was unique to the TCR of this single clone 
110 or whether it could reflect a common pattern for most 
of the KQpecific T cells. To obtain further information to 
answer this question, we tested and combined the recogni- 
tion patterns of 12VSVspecific CTL clones, someof which 
have been previously reported (Imarai et al., 1995) of 2 
Sendai-specific clones (R. S. et al., unpublished data), 
and of 45 H-2Kb-specific alloreactive CTL clones that were 
obtained previously (Bluestone et al., 1986). All the clones 
were individually assayed for their recognition of these 14 
Kb structural mutants listed in Table 2. For each CTL clone, 
the cytolysis level of every R8 mutant was directly com- 
pared with the recognition level of the R8 wild-type cells 
by the same T cell clone to obtain a percentage index 
(Figure 3). If the recognition of a R8 somatic mutant by a 
particular clone was below 25% of that of the R8 wild-type 
cell, we considered this mutation to have a significant im- 
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Figure 4. Bar Graph that Demonstrates How Each of the 14 Mutations 
Affected the Recognition of the H-2K” Molecule by the 59 Different 
CTL Clones Listed in Figure 3 
The graph was made by testing each individual clone against the 14 
R8 mutants and then combining the results in Figure 3. The height 
of the bars represents the percentage of T cell clones out of the total 
number of tested clones whose recognition of the H-2Kb molecule has 
been abolished (closed bar) or partially reduced (hatched bar) by the 
mutation at a particular position. The higher the bar, the more severe 
the negative impact of a mutation on the reactivities of Kb-specific T 
cells. Note that for mutations at positions 56, 58, 79, and 141, the 
heights of the bars are zero, since none of the 59 T cell clones were 
affected by any of these four mutations. 
pact on the T cell recognition and, if between 25% and 
50%, a moderate impact. When the individual patterns 
based on the CTL data of each clone were combined, the 
result, summarized in Figure 4, clearly presented a pattern 
that was consistent with what we observed for clone 110. 
Figure 4 reflects the percentage of clones out of the total 
number of tested clones that are affected by a Kb mutation 
at a particular location. The taller the bar, the higher the 
percentage of the clones that are sensitive to the mutation 
at this position, and therefore the more important this resi- 
due seems for the proper recognition by T cells. Clearly, 
residues in the C-terminal regions of both a helices are 
essential for proper T cell recognition, whereas the muta- 
tions in the N-terminal regions we examined have minimal 
effects, if any at all, on the overall T cell recognition (see 
Figure 2). 
Discussion 
Previous studies involving alloreactjve bm anti-H-2Kb CTL 
clones against a panel of MAb-selected H-2Kb structural 
variants have demonstrated that the TCRs of allogeneic 
CTL clones interact with distinct sets of residues located 
on the two a-helical regions of class I MHC molecules 
(Ajitkumaretal., 1988).Torefinefurtherourunderstanding 
of the involvement of surface-exposed residueson the two 
a helices in interactions with TCRs, we utilized a negative 
selection scheme, employing a CTL clone as a selecting 
reagent, to expand our panel of H-2Kb mutants, and also 
to identify critical structural elements that may otherwise 
not be detectable, either through MAb selection or through 
site-directed mutagenesis. Such an approach enabled us 
to identify two surface-exposed mutations, Arg75 to Gln 
(R8.110.43) and Ala158 toThr (R8.110.2) on the a-helical 
regions of the Kb molecule that could disrupt T cell recogni- 
tion. Judging by their-three dimensional configurations, it 
is probable that the side chains of these surface located 
residues are directly involved in TCR binding but not pep- 
tide binding because the distances between these two 
residues and any peptide residue are beyond the range 
of a hydrogen bond or other types of amino acid interac- 
tion. The isolation of cells expressing Kb with these two 
mutations and the functional behavior of these mutants 
are consistent with the model postulated previously by our 
group that TCRs mainly interact with the surface area of 
the al and a2 domains of the Kb molecule (Ajitkumar et 
al., 1988). Further considering that both mutants have sur- 
vived a prolonged selective pressure exerted by a cytolytic 
T cell clone, the identification of these two mutations is 
direct evidence confirming that, for productive recognition, 
TCRs must simultaneously interact with residues on both 
a helices of the Kb molecule. 
The strategy using a T cell clone as a selecting reagent 
also directly demonstrated that residues in the part of the 
Kb molecule outside the a helices played a role in proper 
TCR recognition. We previously reported a mutation on 
the a3 domain of the Kb molecule that could abolish CTL 
recognition by preventing CD8 binding (Shepherd et al., 
1992). With the same T cell selection strategy, we identi- 
fied a mutation inside the antigen-binding groove (R8.15 
at residue 24) which affected the recognition of the Kb 
molecule by a considerable number of CTL clones. This 
is strong evidence supporting the conclusion from other 
data that the architecture of the peptide-binding groove 
is also critical for TCR recognition. Although the mecha- 
nism by which the mutation at position 24 abolishes T cell 
recognition is not precisely defined yet, we believe it does 
so by changing the set of bound peptides since the side 
chain of residue 24 is in close proximity to the a-carbon 
backbone of a bound peptide @hang et al., 1992; Fremont 
et al., 1992; Townsend et al., 1989; Schumacher et al., 
1990; Hunt et al., 1990). Studies are in progress to com- 
pare the peptides eluted from this mutant molecule and 
the wild-type Kb. 
The most significant finding of our study is the establish- 
ing of a recognition pattern outlined by the residues of 
H-2Kb, which, when mutated, abolish the recognition by 
the TCR of clone 110 (Figure 2). That pattern suggests 
that the TCR is selective in interacting with amino acid 
residues of the Kb molecule, strongly favoring those in the 
C-terminal regions of the two a helices, i.e., the regions 
that extend from amino acid residues 70-90 and from 155- 
174. These two regions also correspond to the two so- 
called hypervariable regions of the class I MHC molecule 
(Klein, 1988). This finding is substantiated by the analysis 
of a panel of 59 anti-Kb CTL clones raised from mice of 
a widely ranging genetic background. The predominant 
pattern recognized by these T cell clones against the panel 
of 14 R8 Kb mutants is essentially similar to that recognized 
by clone 110 (Figures 4 and 5). Analysis of the binding 
patterns of two groups of clones in those 59, the antigen- 
specific clones that recognized H-2Kb as a self-MHC mole- 
cule, and the alloreactive clones that recognized H-2Kb as 
immunity 
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Figure 5. Top View of a GRASP Representation 
Top view of a GRASP representation (Nicholls et al., 1991) of the H-2Kb crystal structure with the VW peptide (shown tubular in red). The Kb 
residues that are believed to play a crucial role for TCR binding based on the data in Figure 3 are shown in blue. A possible interface of H-2Kb- 
TCR interaction emerges as a region that stretches diagonally from the C-terminal region of the al helix to that of the a2 helix. The two red arrows 
point to residues 62 in the al helix and 155 in the a2 helix, the two highest points of the H-2Kb surface, between which the two groups of elevated 
residues demarcate a diagonal depression that follows the trend of B-pleated strands of the Kb molecule. The solvent exposed area of the VSV 
peptide, buried in the antigen-binding groove, is part of this depression. This model suggests that the H-2@ residues located in this depression 
region, as well as the peptide, are primarily responsible for TCR interaction. 
a foreign molecule, showed that their patterns are almost 
identical (Figure 3). Also, while there is variation among 
the patterns of individual clones, the majority of them fit 
the general pattern with little deviation. Thus, irrespective 
of the origins from which T cells arise, they predominantly 
bind the H-2Kb surface in an orientation parallel to the 
P-pleated sheets and diagonal to the a helices. 
It is relevant to note that in the previously analyzed in 
vivo Kbm mutant mice, the locations of all the Kbm muta- 
tions suggest a similar T cell recognition pattern on the 
Kb molecule. A common denominator of the amino acid 
changes found in the spontaneously occurring H-2Kbm 
mice is that most of them are located inside the peptide- 
binding groove (Nathenson et al., 1988). However, the mu- 
tations of the surface-located residues, which also ap- 
peared to affect T cell recognition and to be involved in 
allogenicity, were all concentrated in the diagonal region 
of the a helices as we defined. For instance, the Kb mole- 
cule in bm3 mice has two mutations at positions 77 and 
89; in bml 1 mice, it has two mutations at 77 and 80; and 
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in bm23 mice, two mutations at 75 and 77. Further, the Kb 
molecules of bm4 and bml0 mice both have five mutations 
between positions 162 and 174 on the a2 helix. Thus far, 
no mutant strain has been found to express a Kb molecule 
bearing surface-exposed mutations outside this binding 
pattern. It is important to note that the naturally occurring 
bm mutant mice were generated through mitotic gene re- 
combination, whereas the in vitro R6 mutants were created 
by chemical mutagenesis. The bm mice were identified 
on the basis of allogeneic skin graft rejection, which is a 
different measure of T cell response. Considering that the 
mechanism for the generation and selection of the Kbm 
genes of these mutants is entirely different from that used 
for the isolation of the somatic R6 mutants, the data de- 
rived from these studies are remarkably consistent with 
each other. 
With regard to the scope of diversity of the T cell clones 
we tested, we believe that they represent a wide array 
of T cells from a variety of sources, consisting of both 
allospecific and antigen-specific T cells. The viral-specific 
clones against either VSV or Sendai virus were cloned 
from several independent cultures from 66 mice. The allo- 
reactive clones were derived from 10 different mouse 
strains, including 5 Kbm mutant strains, bml, bm6, bm6, 
bml0, and bml 1, and 5 other strains, BALBlc (H-2d), CBA, 
BlO.GD (H-2Kd, Db), BlO.BR, and C3H mice (Figure 3). 
Based on their recognition behavior on each R6 mutant 
(Figure 3) T cell clones from the same mouse reacted 
differently from one another, and thus did not appear to 
be descended from a single parental cell. Clearly, there 
was no restriction or bias on how these clones were raised. 
Changes in the 14 H-2Kb mutations are for the most 
part quite significant in size, electrical charge, and hydro- 
phobicity of their side chains (Table 2). Of the 14 muta- 
tions, only one, Arg79 to Lys, can be viewed as a conserva- 
tive change. Therefore, the lack of impact on overall TCR 
recognition for mutations at such positions as 56,56, 136, 
and 141, in spite of drastic changes (see Table 2), is com- 
pelling evidence that they are not critically involved in TCR 
binding. Fitting with the idea is the finding that the one 
conservative change that did occur at residue 79 (Arg to 
Lys), within the recognition pattern, failed to affect the 
recognition of H-2Kb by any T cell (Figures 2 and 3). 
We believe that the mechanism by which T cell recogni- 
tion is affected by the surface mutations is due to local 
effects of amino acid side chain alterations rather than to 
drastic shifts in the overall structure. This is because the 
three-dimensional structures of several human and mu- 
rine class I MHC molecules, including both Kb and Db, 
showed that despite multiple amino acid sequence differ- 
ences, the backbonesof different class I MHC allelescould 
be closely superimposed (Garrett et al., 1969; Zhang et al., 
1992; Fremont et al., 1992; Young et al., 1994; Madden, 
1995). It is reasonable that changes on the MHC surface 
tend not to have long range influence on the conformation 
of the entire MHC molecule (Bjorkman et al., 1987b; Gar- 
rett et al., 1989; Joyce et al., 1991; Madden, 1995). We 
believe that either the mutations have disrupted salt links 
or hydrogen bonds that are necessary for productive 
MHC-TCR interaction, or they have created steric hin- 
drance that makes the binding unfavorable. 
Because similar studies on other class I MHC alleles 
have not been carried out with so many mutant targets 
and CTL clones, it is premature for us to broaden our 
conclusion to alleles other than murine H-2Kb. In this re- 
port, we propose that, for the H-2Kb molecule, the two 
C-terminal regions of the a helices are crucially involved 
in the interactions between the H-2Kb molecule and its 
specific TCRs. Several early studies on the murine H-2Ld, 
H-2Kd, and human HLA-A2 mutants using site-directed 
mutagenesis appear to provide support for our conclusion 
in different systems(Koeller et al., 1987; Mann et al., 1988; 
Maryanski et al., 1989; Santos-Aguado et al., 1989; Jaulin 
et al., 1992). For example, CTL clones failed to kill Ld mu- 
tants that had mutations at residues between 63 and 70 
in the al helix (Mann et al., 1988). Mutations around posi- 
tion 70 of the HLA-A2.1 were able to prevent CTL recogni- 
tion (Santos-Aguado et al., 1989). In addition, van Bleek 
et al. (unpublished data) and lmarai et al. (1995) have 
evidence that mutations at positions 62 and 155 can also 
abrogate the recognition of Kb-restricted Sendai-specific 
or VSV-specific T cell clones. Overall, the results obtained 
from these studies either are consistent with or do not 
contradict to our proposed model. 
The TCR-MHC contact area derived from our data is 
also consistent with what has been reported for the class 
II MHC molecules. Studies on various class II alleles sug- 
gest that the hypervariable regions of the class II a and 
8 subunit, i.e., the C-terminal region of each helix, are 
most critical for T cell recognition and for determining allo- 
reactivity (Bill et al., 1989; Barber and Lechler, 1991; Buer- 
stedde et al., 1988, 1989; Cohn et al., 1986; Glimcher 
and Griffith, 1987; Hong et al., 1992; Ehrich et al., 1993). 
Mutations introduced into the top surface of the C-terminal 
half in the helical regions of I-A or I-E molecules led to the 
loss of both allo- and antigen-specific T cell responses, 
while mutations at the N termini did not (Buerstedde et 
al., 1988; Glimcher and Griffith, 1987; Hong et al., 1992; 
Ehrich et al., 1993). Based on this information, we would 
predict that the class II restricted TCRs would assume a 
similar orientation toours. Taking together the results from 
studies on the class II MHC molecules, we believe that 
the common structural features shared by all the MHC 
molecules will give our proposed TCR binding pattern 
broad implications for other MHC alleles as well. 
A computer graphics analysis of the results from our 
study based on the H-2Kb structure has provided insight 
into the structural features of the interface region between 
the H-2Kb molecule and TCRs. An outline of T cell contact 
residues on Kb as defined by our mutational analysis is 
illustrated bytheGRASP(Nichollsetal., 199l)representa- 
tion of the molecular surface of the H-2Kb structure (Figure 
5). Highlighted in blue are the side chains of the C-terminal 
residues of the al helix, 75, 80, and 82, and of the a2 
helix, 158, 162, 166, 167, and 174, which appear to be 
consensus TCR contact residues. Residues 62 and 155, 
the two most membrane-distal points of the two a helices, 
are highlighted by red arrows. On both sides of these two 
elevated points, the a helices slope towards the transmem- 
brane region of the Kb molecule. Thus, the al helix from 
62 towards its C terminus and the a2 helix from 155 to- 
wards its C terminus would provide a depression in the 
molecular surface of the Kb by which a TCR could interlock 
with an MHC molecule. In addition, according to the struc- 
ture, an antigenic peptide such as the VSV peptide used 
in Figure 5 as an example is also a significant part of this 
surface depression. To improve contact with the peptide, 
TCRs would have to conform to the physical constraint 
imposed by the structural features of the H-2Kb mole- 
cule, which are widely shared by most of the MHC alleles 
(Figure 5). 
In summary, we have shown evidence that different 
TCRs may have a common orientation on an MHC target. 
TCRs that are specific for the H-2Kb molecule and its asso- 
ciated peptides interact with both a helices of the Kb mole- 
cule simultaneously in an area extending across the two 
C-terminal stretches of the a helices, i.e., an area that is 
parallel to the b-pleated sheets and diagonal to the a heli- 
ces (Figure 5). The residues not included in this region 
appear to have less impact on the overall T cell recogni- 
tion. The proposed area, which measures about -2,200- 
2,500 AZ would also cover a significant portion of the pep- 
tides bound between the two a helices. Such a binding 
pattern is shared by the overwhelming majority of the Kb- 
specific T cells. This fact suggests that there are inherent 
structural features in the MHC molecules that influence 
T cell recognition, and may actually determine how a TCR 
interacts with the MHClpeptide antigen. Although the data 
is not yet sufficient for us to predict the exact correlation 
between the regions of a TCR and those of the H-2Kb 
molecule, it does imply that the contact sites on the TCR 
may align within this predominant pattern. Recent devel- 
opment in TCR structure studies has shed light on general 
structural features of a TCR 6 chain (Bentley et al., 1995). 
Once the structure of a TCR is available, this pattern pre- 
dicted from our study can potentially be instrumental in 
interpreting and understanding the features of TCR-MHC 
interaction. 
Experimental Procedures 
Mice 
C57BU6 and all the other mouse strains mentioned in this study were 
obtained from either the Jackson Lab (Bar Harbor, Maine) or the Na- 
tional Cancer Institute. Certain bm strains, such as bmS and bm23, 
that were not available from either institutions were maintained at the 
Animal Institute of the Albert Einstein College of Medicine (Bronx, New 
York). 
Cell Lines 
The RS tumor cell line, an Abelson leukemia virus transformed pre-B 
lymphoma, was originally isolated from a (86 x BALB/c)Fl (H-2b x 
H-2”) mouse. The wild-type R6 cells and all the subsequently isolated 
in vitro variants were maintained in either the DME or the RPM1 1640 
medium plus 5% fetal calf serum (FCS). 2 mM glutamine, 50 U/ml of 
penicillin, streptomycin, and gentamycin. 
Alloreactive anti-Kb CTL clone 110 was established as previously 
described (Sheil et al., 1986). Other alloreactive T cell clones were 
either previously reported (Bluestone et al., 1986) or isolated according 
to a standard procedure (Melief et al., 1980). They were maintained 
in Iscove’s medium supplemented with 10% FCS (HyClone), 10% con- 
canavalin A supernatant, 5 x 1Om8 M @mercaptoethanol, 2 mM gluta- 
mine, and various antibiotics. All the clones were stimulated weekly 
with irradiated B6 mouse spleen cells. The VSV-specific and Sendai- 
specific clones were raised by immunizing B6 mice with live VSV or 
Sendai virus, respectively, at l@ pfulmouse. After 4 weeks and one 
additional challenge, spleens were removed from the immunized mice. 
Single cell suspensions were prepared and incubated with either Nl 
cells (EL4 cells transfected with VSV nucleoprotein gene) or RMAls 
cells pulsed with Sendai peptide (FAPGNYPAL, Kast et al., 1991). 
CTL clones were made by limiting dilution (Melief et al., 1960) and 
maintained as described above, except that the culture contained 5nM 
of cognate peptide. 
Peptides 
Peptides used in the CTL assays were synthesized at the Peptide 
Synthesis Facility of the Albert Einstein College of Medicine. They 
were desalted and purified through HPLC gel filtration after synthesis, 
and were identified as genuine by mass spectrometry. The VSV pep 
tide was defined as an octamer with sequence RGYVYOGL (van Bleek 
and Nathenson, 1990) and the Sendai peptide a nonamer with se- 
quence FAPGNYPAL (Kast et al., 1991). 
Isolation of Kb In Vitro Mutants by a CTL Clone 
The isolation and characterization of CTL selected RS mutants was 
as follows. RS cells were mutagenized with EMS at 0.5 mglml (final 
concentration) for approximately 16 hr. Surviving cells were incubated 
with clone 110 cells at an effector:target ratio of 31 to eliminate those 
that still retained the wild-type Kb expression. After 1 week of negative 
selection, resistant cells were subjected to a positive selection scheme 
with a mixture of KQpecific MAbs to separate Kb loss mutants. A 
second round of the above described procedures was repeated to 
ensure a thorough selection. Afterwards, only structural variants with 
a normal MHC expression level, as confirmed by FACS analyses, were 
cloned and expanded for studies. MAbs EH-144, Y-3, Y-25, and 5F1.2 
were used in the above process and also used in the serological char- 
acterizations of all the mutants (Sheil et al., 1986). 
Isolation of Kb In Vitro Mutants by MAbs 
The isolation of RS somatic mutants by H-2KQpecific monoclonal 
antibodies has been described in detail in a previous paper (Geier et 
al., 1986). MAbs EH-144, Y-3, 5F1.2, and 28-13-3 were used to select 
mutant cells. 
Preparation of Total Cellular RNAs from Mutant Cells 
The cloned RS mutants were expanded in the culture till 5 x IO6 cells. 
Total cellular RNAs were extracted as described by Gilman (1987). In 
detail, mutant cells were collected and washed twice with cold phos- 
phate-buffered saline buffer before the cell pellets were lysed in 400 
ul cold lysis buffer (50 mM Tris-HCI [pH S.O], 100 mM NaCI, 5 mM 
MgClr, and 0.5% Nonidet P-40, DEPC treated, and autoclaved) for 5 
min on ice. Cell nuclei and debris were rapidly spun down (13,000 
rpm for 2 min at 4OC) so that DNA contamination was minimized. 
Supernatants were immediately transferred to new tubes that con- 
tained 4 ~120% SDS (at room temperature) and then vigorously mixed 
through votexing. Two rounds of phenol plus chloroform and isoamyl 
alcohol (400 ul, 25:24:1) and chloroformlisoamyl alcohol (400 PI, 
24:l) extraction were performed to get rid of proteins. Total RNAs 
were finally precipitated by dry ice/ethanol, air dried, and resuspended 
in ddH20. All the reagents used to extract or to preserve RNAs were 
pretreated with DEPC and then autoclaved. 
Asymmetric PCR Amplification and Direct DNA Sequencing 
Total RNA (10 ug) was transcribed into cDNAs in reverse transcription 
buffer (120mM Tris-HCI [pHB.O], 25mM MgCI,, 25 mM DTT, O.lmg/ml 
actinomycin D, 2.5mM dNTPs, and AMV reverse transcriptase freshly 
added before usage) at 50°C for 15 min after annealing with Kb-specific 
oligos at Tm 5OC. Oligonucleotides complementary to specific regions 
of the Kb sequence were chemically synthesized at the DNA Synthesis 
Facility of the Albert Einstein College of Medicine (Bronx, New York). 
First-strand cDNAs were precipitated in ethanol and resuspended in 
polymerase chain reaction (PCR) mixture(Perkin-Elmer Cetus)for am- 
plification reactions. The two oligos that served as primers were used 
in unequal amount, with one in 4- or 5-fold excess of the other so 
that single-stranded DNAs could be produced. After 30-40 cycles of 
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amplification following the standard protocol supplied by the vendor 
of theTaq polymerase(Perkin-Elmer Cetus), the remaining oligonucle- 
otides and free dNTPs were separated through Centricon- (Amicon) 
spin column centrifugations at 5,000 rpm x 5 min for four times with 
1 ml TE buffer. Approximately 100 ng of a cleaned product was used for 
each sequencing reaction, based on the routine procedure provided by 
the vendor of Sequenase (United States Biochemical), except that 
10% DMSO was included in the annealing and termination mixtures. 
Cytotoxlc T Cell Assay 
To conduct a 5’Cr release cytolysis assay, target cells were first incu- 
bated with %r at 200 uCi/lOB cells at 37OC for 45 min. Labeled cells 
were washed once prior to further incubation in 5 ml fresh medium 
for 30 min. Labeled target cells (3 x lo3 per well) were distributed 
into 96-well plates in triplicates in a final volume of 200 ul/well of RPM1 
medium (5% FCS). Various effector:target ratios were used as indi- 
cated in each individual assay. After 3.5 hr of incubation at 37’%, 
100 ul of supernatant was collected from test wells and counted on 
a Beckman y counter. The specific lysis was calculated according to 
the following formula: 
Percent of specific lysis = 
Experimental release - Spontaneous release x ,oo 
Maximum release - Spontaneous release 
In the above formula, the maximum %r release was measured by 
breaking target cells in 10% Triton X-l 00 detergent solution, while the 
value of spontaneous release was obtained by measuring the amount 
of %r released into the medium when nothing was added. Whenever 
a peptide antigen was needed, it was diluted to the required concentra- 
tions and then added to the target cells for a 15 min preincubation 
before T cells were introduced. 
Computer Mapping and Modeling 
Structural analyses and amino acid residue mapping were conducted 
on a Silicon Graphics 4000 computer. The mapping of the R8 muta- 
tions on the H-2Kb crystal structure solved by Zhang et al. (1992) was 
conducted with the graphics program GRASP (Nicholls et al., 1991). 
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